Martin Fan
Stock Analyst at Wedbush
(1.38)
# 3,318
Out of 4,843 analysts
5
Total ratings
60%
Success rate
-4.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics | Initiates: Outperform | $8 | $1.46 | +447.95% | 1 | May 28, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Outperform | $40 | $10.95 | +265.30% | 1 | May 15, 2025 | |
| ANAB AnaptysBio | Reiterates: Outperform | $40 | $22.23 | +79.94% | 1 | May 1, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Outperform | $18 | $1.93 | +832.64% | 1 | Mar 25, 2025 | |
| ZBIO Zenas BioPharma | Initiates: Outperform | $35 | $9.61 | +264.20% | 1 | Mar 20, 2025 |
Aclaris Therapeutics
May 28, 2025
Initiates: Outperform
Price Target: $8
Current: $1.46
Upside: +447.95%
Oruka Therapeutics
May 15, 2025
Reiterates: Outperform
Price Target: $40
Current: $10.95
Upside: +265.30%
AnaptysBio
May 1, 2025
Reiterates: Outperform
Price Target: $40
Current: $22.23
Upside: +79.94%
Artiva Biotherapeutics
Mar 25, 2025
Reiterates: Outperform
Price Target: $18
Current: $1.93
Upside: +832.64%
Zenas BioPharma
Mar 20, 2025
Initiates: Outperform
Price Target: $35
Current: $9.61
Upside: +264.20%